Fig. 5From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (Abstract O8). These are the examples in human cancer patients, prostate cancer, Oral cancer, and HBV-induced Liver cancer, where high levels of circulating sMIC correlates with advanced disease stages and poor survival.Back to article page